Clinical trial

Acrylamide and Health Outcomes

NCT06224725

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2004-01-01

PhaseN/A

Study timeline

Study start (actual)2004-01-01Date precision: day

Registry last updated2025-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Dementiaunresolved

Dementia Alzheimersunresolved

Parkinson Diseaseunresolved

Myocardial Infarctionunresolved

Interventions

dietary acrylamide exposure measured via biomarkers in blood (hemoglobin adducts of acrylamide and glycidamide)OTHER

Sponsors & collaborators

Karolinska Institutetlead sponsor

Stockholm Universitycollaborator

Mapped research locations

StockholmSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06224725 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.